Write a Comment

Brian

The dirty little secret behind the media blitz on Gilead's blockbuster drug GS-7977 is that while they had 88% success in the recent trial (after having relapses and threatening WITHDRAWAL of PS-7977-Pharmasett drug they paid 13 billion for) using Abbot's drug needed to help prevent relapse they have opted NOT to file for phase 3 and delay going forward to allow their own drug (of same class as Abbot's) to catch up-this could kill people like me! Consistent greed vs. patient needs-WSJ has POZ?

April 23, 2012 • Beantown